Peak6 Investments LLC Arbutus Biopharma Corp Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$2.23 - $3.1 $691,300 - $961,000	-310,000 Reduced 41.76%	432,400 $1.31 Million
Q4 2022 Feb 10, 2023	BUY	$1.91 - $2.85 $1.23 Million - $1.83 Million	642,300 Added 641.66%	742,400 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $188,188 - $288,288	100,100 New	100,100 $191,000
Q1 2022 May 13, 2022	SELL	$2.42 - $3.98 $1.3 Million - $2.15 Million	-539,200 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.11 - $4.61 $794,916 - $1.18 Million	255,600 Added 90.13%	539,200 $2.1 Million

Q3 2021 Nov 12, 2021	BUY	$2.65 - $4.62 $751,540 - $1.31 Million	283,600 New	283,600 $1.22 Million

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $468M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.